nitazoxanide has been researched along with Liver Cirrhosis in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Abd-Elsalam, SM; Glal, KAM; Mostafa, TM | 1 |
Abd-Elsalam, S; Badawi, R; El-Kalla, F; Elfert, A; Elkhalawany, W; ElSawaf, MA; Elwan, N; Hawash, N; Soliman, S | 1 |
El Kassas, M; El Raziky, M; Esmat, G; Gamil, ME; Hassany, M | 1 |
1 review(s) available for nitazoxanide and Liver Cirrhosis
Article | Year |
---|---|
The future for the treatment of genotype 4 chronic hepatitis C.
Topics: Albumins; Antiviral Agents; Drug Therapy, Combination; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Nitro Compounds; Oligopeptides; Polyethylene Glycols; Proline; Recombinant Proteins; Ribavirin; Serine Proteinase Inhibitors; Thiazoles; Time Factors; Viral Load; Vitamin D | 2012 |
2 trial(s) available for nitazoxanide and Liver Cirrhosis
Article | Year |
---|---|
Nitazoxanide versus rifaximin in preventing the recurrence of hepatic encephalopathy: A randomized double-blind controlled trial.
Topics: Child; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Nitro Compounds; Prospective Studies; Quality of Life; Rifamycins; Rifaximin; Thiazoles | 2021 |
A Randomized Controlled Trial Comparing Nitazoxanide Plus Lactulose With Lactulose Alone in Treatment of Overt Hepatic Encephalopathy.
Topics: Drug Administration Schedule; Drug Therapy, Combination; Female; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Male; Middle Aged; Nitro Compounds; Thiazoles; Treatment Outcome | 2019 |